Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Parathyroid Neoplasms × Cinacalcet × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Parathyroid Neoplasms 2 Hyperparathyroidism, Primary 2 Hypercalcemia 1

Interventions

Cinacalcet 2 evocalcet 1 Tablets 1 Sodium Chloride 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed

46 enrolled 49 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT01460030 2017-03-03

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed

Hypercalcemia, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡